Social Pulse: Abiomed Inc (ABMD.O)
ABMD.O on Nasdaq
Price Change (% chg)
- Abiomed's (ABMD) CEO Michael Minogue on Q1 2015 Results - Earnings Call Transcript
- Q1 2015 Abiomed Inc Earnings Conference Call (Webcast)
- 6 Stocks With High Days-To-Cover Ratios That Could Trap The Bears
- Abiomed's CEO Discusses F4Q 2014 Results - Earnings Call Transcript
- 3 Stocks Spiking on Unusual Volume
- China Biotech In Review: GSK's Q4 China Revenues Actually Point To Recovery
- Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit AgainstAbiomed, Inc.
- United Natural Foods Set to Join the S&P MidCap 400; Abiomed & Ixia to Join S&P SmallCap 600
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In ABIOMED, Inc. To Contact The Firm
- Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Abiomed, Inc.
- Investor Alert: Following Food and Drug Administration Panel Vote, Hagens Berman Reminds Abiomed, Inc. Investors of Jan. 15, 2013, Lead Plaintiff Deadline in Class-Action Lawsuit